Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Compugen Ltd. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
CGEN
Nasdaq
2830
cgen.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Compugen Ltd.
Compugen to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
- Feb 4th, 2025 12:00 pm
Compugen Announces First Patient Dosed in Phase 1 Clinical Trial to Evaluate COM503 as Monotherapy and in Combination with Zimberelimab in Advanced Solid Tumors
- Jan 8th, 2025 12:00 pm
The past five years for Compugen (NASDAQ:CGEN) investors has not been profitable
- Dec 26th, 2024 1:01 pm
Compugen Expands its Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use of COM902 (reduced Fc anti-TIGIT) with anti-PD-1 and anti-PVRIG Antibodies
- Nov 27th, 2024 12:00 pm
Compugen Ltd. (NASDAQ:CGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
- Nov 15th, 2024 10:11 am
Compugen Ltd (CGEN) Q3 2024 Earnings Call Highlights: Promising Developments and Strategic ...
- Nov 13th, 2024 7:08 am
Compugen (CGEN) Q3 Earnings and Revenues Lag Estimates
- Nov 12th, 2024 4:05 pm
Compugen: Q3 Earnings Snapshot
- Nov 12th, 2024 2:56 pm
Compugen Reports Third Quarter 2024 Results
- Nov 12th, 2024 12:00 pm
Compugen to Participate in Stifel 2024 Healthcare Conference
- Nov 11th, 2024 12:00 pm
Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and Pembrolizumab Combination in Patients with Platinum Resistant Ovarian Cancer at SITC 2024
- Nov 5th, 2024 2:00 pm
Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
- Oct 29th, 2024 11:00 am
Compugen Gears Up to Report Q3 Earnings: Here's What to Expect
- Oct 24th, 2024 4:12 pm
Compugen to Present New Clinical Data at SITC 2024
- Oct 7th, 2024 11:00 am
Compugen (CGEN) Upgraded to Strong Buy: What Does It Mean for the Stock?
- Sep 11th, 2024 4:00 pm
Compugen to Present at Single Cell Genomics 2024 Conference
- Sep 9th, 2024 11:00 am
Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Aug 29th, 2024 11:00 am
Can Compugen (CGEN) Run Higher on Rising Earnings Estimates?
- Aug 26th, 2024 4:20 pm
Party Time: Brokers Just Made Major Increases To Their Compugen Ltd. (NASDAQ:CGEN) Earnings Forecasts
- Aug 11th, 2024 1:04 pm
Compugen Ltd. (NASDAQ:CGEN): When Will It Breakeven?
- Aug 7th, 2024 10:03 am
Scroll